You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
PanCAN has invested $25 million in the study, which will screen blood samples from new-onset diabetes patients for biomarkers associated with pancreatic cancer.
The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.
Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.
Based on results from a pilot study, Dutch lawmakers are advancing a proposal to make WGS a standard test for advanced cancer patients.
The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments.